Marketplace®

Daily business news and economic stories
Sep 24, 2021

Monoclonal antibody treatments help with COVID-19, but not without a cost

Also today: In China, property giant Evergrande is about $300 billion in debt, and the deadline to address that debt has come and gone. Is it possible that a bailout could be in the works? There’s been plenty of regulation in store for food delivery apps focused on worker protections, but there are questions about how the app companies might change under this climate. 

Download
Rows of beds and their letter designations are seen in a tent used for monoclonal antibody treatment of COVID-19 patients outside of St. Claire Regional Medical Center on September 16, 2021 in Morehead, Kentucky.
Rows of beds and their letter designations are seen in a tent used for monoclonal antibody treatment of COVID-19 patients outside of St. Claire Regional Medical Center on September 16, 2021 in Morehead, Kentucky.
Jon Cherry/Getty Images

Subscribe:

Segments From This Episode

The Team

Monoclonal antibody treatments help with COVID-19, but not without a cost